Pleconaril (VP 63843) is a novel orally bioavailable small molecule with br
oad antipicornavirus (enterovirus and rhinovirus) activity, Ten independent
ly derived pleconaril-resistant variants of coxsackievirus B3 were isolated
from cell culture. The molecular basis of drug resistance and the biologic
properties of the drug-resistant viruses were investigated. RNA sequence a
nalysis revealed amino acid changes in the drug-binding pocket of the resis
tant variants. Thermal stability studies showed the drug-resistant viruses
to be significantly less stable than wild type virus. When evaluated in a m
urine model in which wild type virus infection is 100% lethal, the drug-res
istant viruses showed attenuated virulence with both reduced mortality and
delayed time to death. Virus titers in heart and spleen were dramatically l
ower in drug-resistant virus-infected mice than in wild type virus-infected
animals. The study results indicate that pleconaril-resistant virus varian
ts are attenuated and significantly less virulent than drug-sensitive wild
type virus.